Vireo Growth Inc. 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds On June 4, 2021, we issued 295,774 subordinated voting shares to a third party for ongoing corporate advisory services. We did not receive any proceeds in connection with the issuance of these shares. The shares issued are subject to a holding period expiring October 5, 2021. ​ 41 Item 6. Exhibits ​ Exhibit No. Description of Exhibit ​ 10.1 ​ Purchase and Sale Agreement and Joint Escrow Instructions, dated September 1, 2021, by and between Vireo Health of New York, LLC and IIP-NY 2 LLC ​ ​ ​ 10.2 ​ First Amendment to Purchase and Sale Agreement and Joint Escrow Instructions, dated September 24, 2021, by and between Vireo Health of New York, LLC and IIP-NY 2 LLC ​ ​ ​ 10.3 ​ Third Amendment to Lease Agreement, dated September 24, 2021, by and between IIP-NY 2 LLC and Vireo Health of New York, LLC ​ ​ ​ 31.1 ​ Rule 13a-14(a)/15d-14(a) certification of Chief Executive Officer ​ 31.2 ​ Rule 13a-14(a)/15d-14(a) certification of Chief Financial Officer ​ 32.1 ​ Section 1350 certification, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 ​ 101 ​ Includes the following financial and related information from Goodness Growth’s Quarterly Report on Form 10-Q as of and for the quarter ended September 30, 2021, formatted in Inline Extensible Business Reporting Language (iXBRL): (1) the Consolidated Balance Sheets, (2) the Consolidated Statements of Income, (3) the Consolidated Statements of Comprehensive Income, (4) the Consolidated Statements of Changes in Stockholders’ Equity, (5) the Consolidated Statements of Cash Flows, and (6) Notes to Consolidated Financial Statements. ​ ​ ​ 104 ​ The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL. ​ ​ ​ ​ ​ 42 SIGNATURES Pursuant to requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ​ ​ GOODNESS GROWTH HOLDINGS, INC. ​ ​ ​ Date: November 10, 2021 By: /s/ Kyle E. Kingsley ​ ​ Name: Kyle E. Kingsley ​ ​ Title: Chief Executive Officer ​ ​ ​ Date: November 10, 2021 By: /s/ John A. Heller ​ ​ Name: John A. Heller ​ ​ Title: Chief Financial Officer ​ ​ ​ ​ ​ ​ 43